查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1320229

奈米医药市场:各适应症，各分子类型，各用途，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年 预测

Nanomedicine Market with COVID-19 Impact Analysis, By Indication, By Molecule Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 364 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年奈米药物市场规模为1809.056亿美元，2023年至2030年复合年增长率为10.9%

奈米医学市场 - 市场动态：

药物传输技术的进步和医疗设施投资的增加预计将推动市场需求

奈米技术将药物精确地输送到需要的地方，从而提高治疗效果。奈米颗粒药物传输系统、奈米胶囊和奈米级药物载体是正在研究的技术之一，旨在提高药物传输的精确度、控制和安全性。随着世界各国政府和商业组织增加对医疗基础设施的投资，奈米医学等先进治疗技术正变得越来越普遍。经合组织的最新估计显示，在政府和强制性计划的推动下，2020 年卫生支出平均增长5%，以满足应对COVID-19 大流行的额外需求。这是由支出异常高的增长（增长8.1 %）推动的。 ）。奈米技术的最新发展为新的奈米医学应用的发展提供了巨大的机会。持续的研究和发展促使疾病治疗和预防的进步。然而，开发和生产医用奈米颗粒的成本很高。这些高成本会降低奈米医学产品的可用性，特别是在发展中国家和贫困地区。

奈米医学市场 - 主要见解：

  • 由于人们对永续成长的认识不断增强，奈米医学产业预计将以显着的速度成长
  • 根据适应症区隔，预计临床肿瘤学将在 2022 年占最大的市场占有率。
  • 从分子类型来看，2022年奈米粒子将是主要类型。
  • 从应用来看，2022年药物传递是主要类型。
  • 按地区划分，北美将在 2022 年实现销售领先。

奈米医学市场 - 区隔分析：

全球奈米医学市场根据适应症、分子类型、应用和区域进行区隔。

市场依适应症分为三类：临床肿瘤学、传染病、临床心臟、骨科和其他。临床肿瘤学预计将主导市场成长。临床肿瘤学、研究和癌症治疗是奈米医学产生重大影响的关键领域。

市场依分子类型分为四大类：奈米颗粒、奈米壳、奈米管、奈米装置。奈米颗粒在市场上占主导地位，并可能在预测期内保持其主导地位。作为利用奈米粒子预防和治疗疾病的医学分支，奈米医学在改变医疗保健方面展现了巨大的潜力。

市场依应用分为四类：治疗、体外诊断、药物传递、体内影像及植入。药物传输领域占市场主导地位。奈米医学在药物传递的应用是医学中最有前途的领域之一。

奈米医学市场 - 地理洞察：

从地区来看，该市场遍布北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些地区根据其开展业务的国家进一步划分。预计北美将主导奈米医学市场的成长。人们越来越认识到奈米技术在医疗保健方面的好处、慢性病和危及生命的疾病的扩散以及人口老化正在推动北美对奈米医学的需求。据美国疾病管制与预防中心 (CDC) 称，美国每年 3.8 兆美元的医疗保健支出中有 90% 用于患有慢性病和精神健康问题的人。根据最近发布的《对抗慢性病伙伴关係》报告，到2030 年，治疗七种最常见的慢性病，??再加上生产力损失，将给美国经济造成每年2 兆美元的损失，即每人8,600 美元。由于拥有先进的医疗设施和训练有素的医疗专业人员、强大的研发活动以及主要参与者的存在，预计欧洲和亚太地区将在预测期内主导市场，预计将推动成长。

奈米医学市场竞争格局：

奈米医学市场是一个快速成长的新兴市场，由于慢性病的流行、人口老化和技术进步，全球需求不断增加。公司正大力投资研发，以开发创新的奈米医学解决方案。竞争优势是基于技术创新和开发产品的功效。许多公司结盟和合作，以降低研发成本并推动产品开发和批准。这些合作通常涉及专业知识和资源的交流，帮助公司获得竞争优势。例如，2022年10月21日，GE医疗集团与Accuray Incorporated宣布建立全球合作伙伴关係，共同开发解决方案，使世界各地更多的医疗团队能够在治疗过程中的任何时刻调整患者护理，并宣布达成商业合作伙伴协议。两家公司将共同提供全面的产品，将GE Healthcare 的精准诊断工具与Accuray Incorporated 的创新放射治疗交付能力相结合，推动放射治疗实践的发展，帮助癌症患者接受个人化治疗。使患者能够接受标准化治疗。

目录

第1章 奈米医药市场概要

  • 调查范围
  • 市场估计年数

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 奈米医药的主要市场趋势

  • 奈米医药推动市场要素
  • 奈米医药阻碍市场要素
  • 奈米医药市场机会
  • 奈米医药市场今后趋势

第4章 奈米医药产业的调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 奈米医药市场:COVID-19影响分析

  • COVID-19前的影响分析
  • COVID-19后的影响分析

第6章 奈米医药市场形势

  • 奈米医药市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 现有企业的分析
    • 新兴企业的分析

第7章 奈米医药市场- 各适应症

  • 概要
    • 各适应症的市场区隔占有率分析
    • 临床肿瘤
    • 感染疾病
    • 临床心臟
    • 整形外科
    • 其他

第8章 奈米医药市场- 各分子类型

  • 概要
    • 各分子类型的市场区隔占有率分析
    • 奈米粒子
      • 金属·金属氧化物奈米粒子
      • 微脂体
      • 聚合物·聚合物药物复合体
      • 水凝胶奈米粒子
      • 树状聚合物
      • 无机奈米粒子
    • 奈米贝壳
    • 奈米碳管
    • 奈米设备

第9章 奈米医药市场- 各用途

  • 概要
    • 各用途的市场区隔占有率分析
    • 治疗
    • 体外诊断
    • 药物输送
    • 生物内成像
    • 植入

第10章 奈米医药市场-各地区

  • 简介
  • 北美
    • 概要
    • 主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 主要製造商
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第11章 主要供应商分析- 奈米医药产业

  • 竞争仪表板
  • 企业简介
    • Abbott Laboratories
    • CombiMatrix Corporation
    • Celgene Corporation
    • Nanospectra Biosciences, Inc.
    • GE Healthcare
    • Johnson &Johnson Services, Inc.
    • Mallinckrodt Pharmaceuticals
    • Merck &Co., Inc.
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Arrowhead Pharmaceuticals, Inc.

第12章 分析师的全方位展望

Product Code: ANV1540

REPORT HIGHLIGHT

Nanomedicine Market size was valued at USD 180,905.6 Million in 2022, expanding at a CAGR of 10.9% from 2023 to 2030.

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nonmetric scale 10-9 m which often differ in terms of physics, chemistry, or biology from the same material at a bigger scale. Nanomedicine offers the potential to provide early detection and prevention, as well as significantly enhance diagnosis, therapy, and follow-up for a wide range of diseases, including cancer. Overall, numerous Nanomedicine items are currently in clinical trials, spanning all main disorders such as cardiovascular, neurological, musculoskeletal, and inflammatory. Nanomedicine, which enables advancements in all sectors of healthcare, now accounts for over 80 marketed items, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics, and biomaterials.

Nanomedicine Market- Market Dynamics:

Rising advancing technologies for drug delivery and Growing investment in healthcare facilities are expected to propel market demand

Nanotechnology provides medications to be delivered to the exact recognition where they are needed, increasing therapy effectiveness. Nanoparticle drug delivery systems, nano-encapsulation, and nanoscale drug carriers are among the technologies being researched to improve the precision, control, and safety of drug delivery. As governments and commercial entities around the world boost their investment in healthcare infrastructure, sophisticated treatment techniques such as Nanomedicine are becoming more popular. Latest OECD estimates point to average health expenditure growth of 5% in 2020, driven by the exceptionally high growth in spending by government and compulsory schemes (+8.1%) in response to the additional need to address the COVID-19 pandemic. Recent developments in nanotechnology provide enormous opportunities for the development of new Nanomedicine applications. Continuous research and development can result in advancements in illness treatment and prevention. However, the development and production of nanoparticles for medical use can be expensive. These high costs can make Nanomedicine products less accessible, especially in developing and underprivileged regions.

Nanomedicine Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Nanomedicine market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2023-2030)
  • The Nanomedicine industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Indication segmentation, Clinical Oncology was predicted to show maximum market share in the year 2022
  • Based on Molecular type segmentation, Nanoparticles were the leading type in 2022
  • Based on Application segmentation, drug delivery was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nanomedicine Market- Segmentation Analysis:

The Global Nanomedicine Market is segmented on the basis of Indication, Molecular type Application, and Region.

The market is divided into three categories based on Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others. Clinical Oncology is expected to dominate the market growth. Clinical oncology, the research, and cancer treatment is one of the key sectors where Nanomedicine has a substantial influence.

The market is divided into four categories based on Molecule Type: Nanoparticles, Nanoshells, Nanotubes, and Nanodevices. Nanoparticles dominate the market and are likely to maintain their dominance during the forecast period. As a subfield of medicine that uses nanoparticles to prevent and treat diseases, Nanomedicine has been showing remarkable potential for transforming healthcare.

The market is divided into four categories based on Application: Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging, and Implants. The drug delivery segment dominates the market. The application of Nanomedicine in drug delivery is one of the most promising areas of healthcare.

Nanomedicine Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Nanomedicine Market. Growing awareness of the prospective benefits of nanotechnology in healthcare, a surge in chronic and life-threatening diseases, and a population that is aging are all fueling up demand for Nanomedicine in North America. According to the CDC, 90% of the nation's USD3.8 trillion per year healthcare costs can be attributed to people with chronic diseases and mental health conditions. A recent Partnership to Fight Chronic Disease publication determined that treatment of the seven most common chronic diseases, coupled with productivity losses, will cost the U.S. economy USD2 trillion dollars annually USD8,600 per person, by 2030. Europe and Asia Pacific region are expected to drive market growth in the forecast period, due to the availability of advanced healthcare facilities with trained medical professionals, a rise in the number of R&D activities along with the large presence of key players.

Nanomedicine Market- Competitive Landscape:

The Nanomedicine Market is a rapidly growing emerging area with rising demand worldwide driven by the increasing prevalence of chronic diseases, aging populations, and technological improvements. Companies are heavily investing in R&D in order to develop revolutionary Nanomedicine solutions. The competitive advantage is based on technological innovation and the efficacy of developed items. Many companies are entering into partnerships and collaborations to reduce R&D expenses and advance product development and approval. These collaborations frequently involve the exchange of expertise and resources, which can help businesses obtain a competitive advantage. For example, on 21 Oct, 2022, GE Healthcare and Accuray Incorporated announced nowadays global commercial collaboration agreement to develop solutions that will allow more healthcare teams across the world to adapt patients' care at every point of their treatment path. The two companies will make available a comprehensive offering that combines GE Healthcare's precision diagnostic tools and Accuray Incorporated's innovative radiation therapy delivery capabilities to advance radiation therapy practice and help patients diagnosed with cancer gain personalized care.

Recent Developments:

On 9 January 2023, A novel combination of artificial intelligence and production techniques could change the future of Nanomedicine, according to Cornell researchers using a new USD3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.

Key features of the study:

  • This proposed research study on Nanomedicine market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Nanomedicine market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Nanomedicine market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Nanomedicine market
  • Impact of COVID-19 on Nanomedicine market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Nanomedicine market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Nanomedicine market, we have also included competitive landscape and key innovator analysis for the Nanomedicine market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Nanomedicine market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Nanomedicine market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINE MARKET KEY PLAYERS

  • Abbott Laboratories
  • CombiMatrix Corporation
  • Celgene Corporation
  • Nanospectra Biosciences, Inc.
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Arrowhead Pharmaceuticals, Inc.

GLOBAL NANOMEDICINE MARKET, BY INDICATION

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

GLOBAL NANOMEDICINE MARKET, BY MOLECULE TYPE

  • Nanoparticles
  • Metal & Metal Oxide Nanoparticles
  • Liposomes
  • Polymers & Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

GLOBAL NANOMEDICINE MARKET, BY APPLICATION

  • Therapeutics
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

GLOBAL NANOMEDICINE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nanomedicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nanomedicine Market Snippet by Indication
    • 2.1.2. Nanomedicine Market Snippet by Molecule Type
    • 2.1.3. Nanomedicine Market Snippet by Application
    • 2.1.4. Nanomedicine Market Snippet by Country
    • 2.1.5. Nanomedicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Nanomedicine Key Market Trends

  • 3.1. Nanomedicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nanomedicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nanomedicine Market Opportunities
  • 3.4. Nanomedicine Market Future Trends

4. Nanomedicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nanomedicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nanomedicine Market Landscape

  • 6.1. Nanomedicine Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nanomedicine Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Clinical Oncology
    • 7.1.3. Infectious Diseases
    • 7.1.4. Clinical Cardiology
    • 7.1.5. Orthopedics
    • 7.1.6. Others

8. Nanomedicine Market - By Molecule Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Molecule Type, 2022 & 2030 (%)
    • 8.1.2. Nanoparticles
      • 8.1.2.1. Metal & Metal Oxide Nanoparticles
      • 8.1.2.2. Liposomes
      • 8.1.2.3. Polymers & Polymer Drug Conjugates
      • 8.1.2.4. Hydrogel Nanoparticles
      • 8.1.2.5. Dendrimers
      • 8.1.2.6. Inorganic Nanoparticles
    • 8.1.3. Nanoshells
    • 8.1.4. Nanotubes
    • 8.1.5. Nanodevices

9. Nanomedicine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Therapeutics
    • 9.1.3. In-vitro Diagnostics
    • 9.1.4. Drug Delivery
    • 9.1.5. In-vivo Imaging
    • 9.1.6. Implants

10. Nanomedicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nanomedicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nanomedicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nanomedicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nanomedicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nanomedicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Nanomedicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. CombiMatrix Corporation
    • 11.2.3. Celgene Corporation
    • 11.2.4. Nanospectra Biosciences, Inc.
    • 11.2.5. GE Healthcare
    • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.7. Mallinckrodt Pharmaceuticals
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Pfizer, Inc.
    • 11.2.10. Teva Pharmaceutical Industries Ltd.
    • 11.2.11. Arrowhead Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicine Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicine Market, by Indication 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Molecule Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicine Market, by Molecule Type 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicine Market, by Application 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicine Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nanomedicine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Molecule Type segment market share analysis, 2022 & 2030
  • FIGURE Molecule Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nanomedicine Market share and leading players, 2022
  • FIGURE Europe Nanomedicine Market share and leading players, 2022
  • FIGURE Asia Pacific Nanomedicine Market share and leading players, 2022
  • FIGURE Latin America Nanomedicine Market share and leading players, 2022
  • FIGURE Middle East and Africa Nanomedicine Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nanomedicine Market share analysis by country, 2022
  • FIGURE Germany Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nanomedicine Market share analysis by country, 2022
  • FIGURE India Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market share analysis by country, 2022
  • FIGURE Brazil Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)